"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
May 22, 2024 at 10:22 AM
3 minute read
Litigation Reporter
The original version of this story was published on Connecticut Law Tribune
Lawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to deter competitors from creating generic alternatives to prescription drugs continue to grow.
Teva Pharmaceutical Industries, for instance, was hit with two antitrust class actions in Massachusetts federal court.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Credit: ronstik/Adobe Stock
